NIH award NIH awarded $580K (SBIR Phase II 5R44AI183961-03, continuation, notice Aug 11, 2026); since then posted 4 roles. NIH RePORTER 5R44AI183961-03 (Aug 11, 2026)Evidence (1 event)
Aug 11, 2026 · NIH RePORTER 5R44AI183961-03 Organization: OSSIUM HEALTH, INC.; City/State: SAN FRANCISCO, CA; Project number: 5R44AI183961-03; Activity code: R44; Fiscal year: 2026; Award notice date: 2026-08-11; FY total cost (award amount): 579970; Administering IC: National Institute of Allergy and Infectious Diseases; Project title: Developing a bank of purified myeloid progenitor cells as a bridging therapy for transient pancytopenia resulting from radiation injury; Organization type: Domestic For-Profits
Trial start Not phased (device or behavioral study): Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies source ↗
Board tracked Radar started tracking this company’s job board (8 open jobs at last check). source ↗
Grant Government grant — SBIR: $579,970 (annual award, as published), announced Aug 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Grant Government grant — SBIR: $1M (annual award, as published), announced Sep 2, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
Trial start Phase 1/Phase 2: A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies source ↗
Trial start —: HPC Offered for PRESERVE Expansion source ↗
Mar 31, 2029 (ESTIMATED) · Not phased · Study to Characterize Mismatched to Fully HLA-Matched Ossium HPC, Marrow and Living Donor Transplantation in Patients With Hematologic Malignancies · NCT07710781
Estimated primary completion per ClinicalTrials.gov. Dates move.
Field Based: Northern Indiana; Field Based: Southern Indiana
Dec 31, 2025
Oct 9, 2026
Entry
Level (Entry/Mid/Senior/Executive) is estimated from the job title and required years of experience. Descriptions are short excerpts (about the first 60 words) of the posting plus skills picked out of it; use Read full posting for the complete text.
Funding
Last 2 years.
Government grant — SBIR: $579,970 (annual award, as published), announced Aug 11, 2026. Agency: NIH/NIAID. Source: government award database. source ↗
Government grant — SBIR: $1M (annual award, as published), announced Sep 2, 2025. Agency: NIH/NIAID. Source: government award database. source ↗
A First-in-Human Study of HLA-Partially to Fully Matched Allogenic Cryopreserved Deceased Donor Bone Marrow Transplantation for Patients With Hematologic Malignancies
Mesenchymal Stem Cells (MSCs) for Perianal Fistula
Phase 1
Withdrawn
2022-08
2024-04 (estimated)
NIH awards 19
Annual award amounts. Total $8.3M.
NIH award 1R44AI183961-01A1 FY2024: $375,113 awarded for that fiscal year; activity R44 (SBIR); PI JOHNSTONE, BRIAN H.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Developing a bank of purified myel source ↗
NIH award 5U01AI138334-05 FY2022: $572,754 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. OssioStem-matched multipotent MSC (M source ↗
NIH award 1R41HL155004-01A1 FY2021: $248,452 awarded for that fiscal year; activity R41 (STTR); PI CORNETTA, KENNETH; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. A novel approach to Mesenchymal Stem source ↗
NIH award 1R41GM140787-01A1 FY2021: $224,453 awarded for that fiscal year; activity R41 (STTR); PI HOPEWELL, EMILY; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Reducing a major cost burden of therap source ↗
NIH award 5R43AI155196-02 FY2021: $142,485 awarded for that fiscal year; activity R43 (SBIR); PI JOHNSTONE, BRIAN H.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. A Novel and Clinically Feasible Co-t source ↗
NIH award 5U01AI138334-04 FY2021: $928,679 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. OssioStem-matched multipotent MSC (M source ↗
NIH award 5R44HL142418-03 FY2021: $687,302 awarded for that fiscal year; activity R44 (SBIR); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Novel strategies for storage and recovery source ↗
NIH award 3U01AI138334-03S1 FY2021: $68,541 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. OssioStem-matched multipotent MSC ( source ↗
NIH award 1R43AI155197-01 FY2020: $299,998 awarded for that fiscal year; activity R43 (SBIR); PI JOHNSTONE, BRIAN H.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Developing a bank of purified myeloi source ↗
NIH award 1R43AI155196-01 FY2020: $157,465 awarded for that fiscal year; activity R43 (SBIR); PI JOHNSTONE, BRIAN H.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. A Novel and Clinically Feasible Co-t source ↗
NIH award 5U01AI138334-03 FY2020: $494,963 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. OssioStem-matched multipotent MSC (M source ↗
NIH award 5R44AI129444-03 FY2020: $999,998 awarded for that fiscal year; activity R44 (SBIR); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Optimizing Industrial-Scale GMP Processes source ↗
NIH award 2R44HL142418-02 FY2020: $778,661 awarded for that fiscal year; activity R44 (SBIR); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Novel strategies for storage and recovery source ↗
NIH award 2R44AI129444-02 FY2019: $682,556 awarded for that fiscal year; activity R44 (SBIR); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Optimizing Industrial-Scale GMP Processes source ↗
NIH award 5U01AI138334-02 FY2019: $601,224 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. OssioStem-matched multipotent MSC (M source ↗
NIH award 1U01AI138334-01 FY2018: $323,360 awarded for that fiscal year; activity U01 (OTHER_NIH); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. OssioStem-matched multipotent MSC (M source ↗
NIH award 1R43HL142418-01 FY2018: $224,961 awarded for that fiscal year; activity R43 (SBIR); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Novel strategies for storage and recovery source ↗
NIH award 1R43HL139315-01 FY2017: $239,080 awarded for that fiscal year; activity R43 (SBIR); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Novel Disaccharide-Based Cryopreservation source ↗
NIH award 1R43AI129444-01A1 FY2017: $272,587 awarded for that fiscal year; activity R43 (SBIR); PI WOODS, ERIK J.; recipient as written: OSSIUM HEALTH, INC., SAN FRANCISCO, CA. Deceased Donor Bone Marrow Salvage and source ↗
